Aggressive Periodontitis Clinical Trial
Official title:
Comparison Of Er,Cr:YSGG and Diode Laser on the Periodontal Parameters and Cytokines Levels in Patients With Generalized Aggressive Periodontitis
The aim of our study is to determine the interleukin-1βeta (IL-1β), interleukin-8 (IL-8) and tumor necrosis factor-αlfa (Tnf-α) levels in gingival crevicular fluid (GCF) and clinical periodontal parameters following the treatment with Erbium,Chromium:Yttrium-Scandium-Gallium-Garnet (Er,Cr:YSGG) and diode lasers in adjunct to scaling and root planing (SRP) in patients with generalized aggressive periodontitis (GAgP). Twenty-six patients with GAgP (n=26) were enrolled in the study. The study was designed as a "split-mouth" study. In each patient, three quadrants were randomly determined as SRP-control, SRP+Er,Cr:YSGG and SRP+Diode laser. Clinical periodontal measurements were recorded at the baseline and third month after the treatment. Cytokines levels in GCF were determined by enzyme-linked immunosorbent assay (ELISA).
A total of 26 individuals were included in our study. Diagnoses were made after the clinical
and radiographic examinations on patients who applied to the Yuzuncu Yil University Faculty
of Dentistry, Department of Periodontology Clinics in 2014-2015. It was ensured that the
individuals who were included in the study did not have any systemic diseases; were not
menopausal, pregnant or lactating; had not used antibiotics or any other medication
affecting the immune system in the previous six months; were non-smokers; had at least 16
teeth in their mouth; and had not received any periodontal treatment in the previous 6
months. The subjects involved in the study were told the aim and content of the study by a
clinician, and they signed an approval form stating that they voluntarily participated in
the survey. Each individual read the Helsinki Declaration before joining the study. The
Human Ethics Research Committee of Yuzuncu Yil University
(no.B.30.2.YYU.0.01.00.00/44-100912) gave the approval to carry out the study.
The including criteria were applied in diagnosing generalized aggressive periodontitis
(International Workshop for Classification of Periodontal Diseases in 1999). Clinical
periodontal assessments, including periodontal status, were conducted by measuring the
bleeding on probing (BOP), plaque index (PI), gingival index (GI), probing pocket depth
(PPD) and clinical attachment level (CAL) at 6 sites per tooth by another clinician. The
clinical periodontal indices measured during the research were evaluated site-specifically
by including the mesial and distal of those teeth from which GCF samples were obtained.
All individuals received non-surgical initial periodontal treatment. At the baseline of the
study all quadrants were shown the similarity of periodontal disease. The procedures
outlined below were applied to all individuals in the study in randomly selected three
different quadrants. The study was designed as a "split-mouth" study.
1. Only SRP group (SRP-Control)
2. SRP+Er,Cr:YSGG laser group (SRP+Er,Cr:YSGG)
3. SRP+940±15 nm diode laser group (SRP+Diode) GCF sample sites were selected after
probing measurements were taken. The GCF samples were collected at the baseline of the
study and on the 3rd month following treatment. The GCF samples were taken from the
deepest pocket in all quadrants. The samples were collected with paper strips
(Periopaper Oraflow, NewYork, USA) that were cut in standard size. Before the sampling
procedure, supragingival plaque was removed and then the sites were isolated from
saliva with sterile buffer and sterile cotton rolls. The sampled tooth surfaces were
dried by slightly blowing air on them. The paper strips were inserted until a light
resistance in the sulcus was felt, and they were left there for 30 seconds. The strips
that were contaminated with blood were not included in the evaluation. The fluid amount
was measured by a Periotron device (Periotron 8000, Oraflow, NewYork, USA) and was
converted to GCF volume in ml units. The four strips which were obtained from every
patient were placed into individual Eppendorf tubes, each of which contained 500 μl of
liquid (Phosphate Buffer Saline (PBS)-pH 7.4) and a paper strip and were stored at -80o
C.
SRP was first performed to the control quadrants of the individuals diagnosed with GAgP;
following the SRP procedure, the Er,Cr:YSGG laser was applied. The 940±15 nm diode laser was
applied prior to SRP, unlike the Er,Cr:YSGG laser (to prevent changing the diode laser
efficiency following bleeding). In the study, the Er,Cr:YSGG laser (Waterlase, Biolase,
Irvine, CA, USA) and the 940±15 nm diode laser (Ilase, Biolase, Irvine, CA, USA) were used.
For the Er,Cr:YSGG laser, a 14-mm Z-6 tip (600 μm fiberoptic tip, suitable for periodontal
use) marked to the depth of the pocket was used at a setting of 10 Hz, 1.5 W (150 mJ), 65%
air, 55% water with H mode, 140 μs pulse length. The total irradiation time was 30 s. The
940±15 nm diode laser with MZ6-14 mm standard tip was used at a setting in continuous wave
mode. The irradiation times for 940±15 nm diode laser were adjusted to 20 s.
The TNF-α, IL-1β and IL-8 analysis in GCF was conducted through the ELISA method by means of
commercial ELISA kits.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05043935 -
The Effect of Leukocyte and Platelet-rich Fibrin With Antimicrobial Photodynamic Therapy in Aggressive Periodontitis
|
N/A | |
Terminated |
NCT01993368 -
Analysis of Osteoimmune Interactions Linking Inflammation and Bone Destruction in Aggressive Periodontitis
|
N/A | |
Completed |
NCT02282800 -
Immunolocalization of 1,25,Dihydroxyvitamin D3 in Aggressive Periodontitis Patients
|
N/A | |
Recruiting |
NCT02833285 -
B Cell Functions in Periodontitis
|
||
Completed |
NCT02127203 -
Nitro-oxidative Stress in Periodontitis
|
N/A | |
Completed |
NCT02223702 -
Alternative Antibiotic Regime in the Treatment of GAgP
|
Phase 4 | |
Completed |
NCT03093207 -
Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT03093246 -
Omega-3 Plus Low-dose Aspirin Daily Supplementation in Non-surgical Therapy to Treat Aggressive Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT05295576 -
Effect of Non Surgical Periodontal Therapy on Inflammatory Markers in Chronic Periodontitis Patients
|
||
Completed |
NCT05297084 -
Non Surgical Periodontal Treatment Effect on Il-17 and Il-18 in Aggressive Periodontitis
|
||
Completed |
NCT02969928 -
Two Different Antibiotic Agents to Treat Generalized Aggressive Periodontitis
|
Phase 2/Phase 3 | |
Completed |
NCT02829983 -
Clarithromycin as Adjuvant to Periodontal Debridement
|
N/A | |
Completed |
NCT02927704 -
Gingival Crevicular Fluid Levels Of Monocyte Chemoattractant Protein-1
|
N/A | |
Completed |
NCT02817568 -
Frequency Of MCP-1 And CCR2 Gene Polymorphisms And Its Effect On Gene Expression In Patients With AgP
|
N/A | |
Active, not recruiting |
NCT04051255 -
Influence of Smoking on Clinical, Microbiological and Immunologic Parameters in Patients With Aggressive Periodontitis.
|
N/A | |
Completed |
NCT05001919 -
Concentrated Growth Factors in Treatment of Intrabony Defects in Localized Aggressive Periodontitis
|
Phase 1/Phase 2 | |
Completed |
NCT03727620 -
Doxycycline in the Treatment of Aggressive Periodontitis
|
Phase 1/Phase 2 | |
Completed |
NCT04223869 -
IL-34 Levels in Various Types of Periodontitis
|
N/A | |
Completed |
NCT02049008 -
Treatment of Aggressive Periodontitis With Repeated Adjunctive Antimicrobial Photodynamic Therapy
|
Phase 4 | |
Recruiting |
NCT01510808 -
The Affect of Orthodontic Treatment on the Periodontal Status of Patients With Aggressive Periodontitis
|
N/A |